By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Civitas Therapeutics 

190 Everett Ave.

Chelsea  Massachusetts  02150  U.S.A.
Phone: 617-968-3004 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Civitas Therapeutics Announces Positive Phase 2b Results For CVT-301, Inhaled Levodopa For The Treatment Of Parkinson’s Disease 4/28/2014 9:29:09 AM
Civitas Therapeutics To Present At The 21st Annual Future Leaders In The Biotech Industry Conference 3/24/2014 9:30:47 AM
Civitas Therapeutics To Present At Cowen and Company 34th Annual Health Care Conference 2/25/2014 7:31:27 AM
Civitas Therapeutics To Present At 2014 Leerink Swann and Company Global Healthcare Conference 2/6/2014 7:24:42 AM
Civitas Therapeutics Appoints Mark Iwicki President And Chief Executive Officer 1/29/2014 7:21:59 AM
Civitas Therapeutics Appoints Timothy S. Nelson As Chairman Of The Board Of Directors 1/8/2014 8:49:24 AM
Civitas Therapeutics To Present At Piper Jaffray And Oppenheimer Investor Conferences In December 11/26/2013 7:06:19 AM
Civitas Therapeutics Extends CVT-301 Patent Protection Into 2032 11/8/2013 9:48:44 AM
Civitas Therapeutics Raises $38 Million 9/11/2013 6:58:22 AM
Civitas Therapeutics Initiates Phase 2b Clinical Study of CVT-301, Inhaled L-dopa for Parkinson’s Disease 9/5/2013 10:23:18 AM
123
//-->